Comparing Non-Vitamin K Oral Anticoagulants: Where We Are Now
- PMID: 27695820
- DOI: 10.1001/jamainternmed.2016.6429
Comparing Non-Vitamin K Oral Anticoagulants: Where We Are Now
Comment in
-
Dabigatran Compared With Rivaroxaban vs Warfarin-Reply.JAMA Intern Med. 2017 May 1;177(5):744. doi: 10.1001/jamainternmed.2017.0571. JAMA Intern Med. 2017. PMID: 28460106 No abstract available.
Comment on
-
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.JAMA Intern Med. 2016 Nov 1;176(11):1662-1671. doi: 10.1001/jamainternmed.2016.5954. JAMA Intern Med. 2016. PMID: 27695821
Similar articles
-
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.Clin Interv Aging. 2015 Sep 3;10:1431-44. doi: 10.2147/CIA.S80641. eCollection 2015. Clin Interv Aging. 2015. PMID: 26366064 Free PMC article. Review.
-
Clinical Stroke prevention in atrial fibrillation.J R Coll Physicians Edinb. 2017 Mar;47(1):13-23. doi: 10.4997/JRCPE.2017.105. J R Coll Physicians Edinb. 2017. PMID: 28569277 Review.
-
Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?Int J Cardiol. 2018 Apr 1;256:39. doi: 10.1016/j.ijcard.2017.10.113. Int J Cardiol. 2018. PMID: 29454418 No abstract available.
-
[Treatment safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation].Herz. 2016 Feb;41(1):37-47. doi: 10.1007/s00059-015-4383-3. Herz. 2016. PMID: 26669316 German.
-
Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.Semin Thromb Hemost. 2015 Mar;41(2):146-53. doi: 10.1055/s-0035-1544156. Epub 2015 Feb 15. Semin Thromb Hemost. 2015. PMID: 25682085 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
